Colorado BioScience Association Explores New Possibilities for Medtech at Annual Symposium

Medical device industry leaders to focus on blockchain technology, M&A trends and federal policy

DENVER – Colorado BioScience Association (CBSA) focuses on the opportunities offered by blockchain technology for medical device companies with insights from Colorado thought leaders focused on blockchain adoption in healthcare, including BurstIQ and CORHIO, at its annual Medical Device Symposium. The event will be held at the Westin Westminster on March 7.

Jennifer Jones Paton, President & CEO of CBSA, says:

“Colorado is an emerging blockchain technology hub and medical devices rank among our state’s top exports. We’re pleased to bring innovators in these technologies together to explore the potential of blockchain to advance healthcare and support improved health and quality of life for patients.”

Additionally, speakers and panelists will provide their perspectives on developing and launching new products, discuss the M&A outlook and review federal policies impacting medical device manufacturers in sessions including:

• Federal policy preview by Brendan Benner, Vice President of Public Affairs for the Medical Device Manufacturers Association.

• New national data and insights on the medtech sector from Derek Riesenberg, Managing Director, EY-Parthenon Life Sciences Practice.

• Panel discussion: Leaders in MedTech, led by Dan Wittenberg, Partner at Snell & Wilmer.

• Panel discussion: Blockchain’s Disruptive Technology, led by Eric Kintner, Partner at Snell & Wilmer.

Sponsors of the symposium include: Snell & Wilmer, Fitzsimons Innovation Community, and EY.

The conference will be held on March 7, 2019 from 1:30 p.m.-5:00 p.m. at the Westin Westminster – Lakehouse, 10600 Westminster Blvd. Registration is $50 for CBSA members and $100 for non-members.

Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn

About the Colorado BioScience Association

Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at

Media Contacts:

Sheliah Reynolds

Primavera Group for Colorado BioScience Association

(720) 289-4739

Categories: CBSA News